Session 9: Management of COPD

Slides:

Advertisements

Similar presentations

Volume 34, Issue 2, Pages (August 1958)

Advertisements

Tell-tale Telangiectasias

Esophageal Cancer CHEST

Chest X-ray Screening Improves Outcome in Lung Cancer

Colloquium on Therapy of Right Heart Failure

Volume 74, Issue 5, Pages (November 1978)

Assessment of Bronchodilator Efficacy in Symptomatic COPD

Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke

The Chicago Asthma Surveillance Initiative

When to Be Rash About a Fever and Headache

The Role of Induction (Neoadjuvant) Chemotherapy in Stage IIIA NSCLC

Volume 102, Issue 3, Pages (September 1992)

Pulmonary Function and Symptoms in Herbal Tea Workers

Antanas G. Razma, M. D. , F. C. C. P. , Joseph P. Lynch, M. D. , F. C

Efficacy of Inhalational Nitric Oxide Therapy in the Clinical Management of Persistent Pulmonary Hypertension of the Newborn John P. Kinsella, M.D.,

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

Volume 127, Issue 6, Pages (June 2005)

Air Pollution and Chest Disease

Navin K. Jain, MD, Thiam H. Lie, MD, FCCP CHEST

Bruce K. Rubin, MEngr, MD, FCCP, Markus O. Henke, MD CHEST

Volume 94, Issue 4, Pages (October 1988)

Clinical and Personality Profiles and Survival in Patients With COPD

Effects of Prostaglandin E1 on Oxygen Delivery and Consumption in Patients with the Adult Respiratory Distress Syndrome Henry J. Silverman, M.D., F.C.C.P.

Oxygen Therapy Titrated to Raise Mixed Venous Oxygen Content in COPD

Volume 115, Issue 3, Pages 19S-23S (March 1999)

Bacterial Infection and the Pathogenesis of COPD

Volume 113, Issue 4, Pages (April 1998)

Ann J. Woolcock, M.D., F.C.C.P. CHEST

Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD CHEST

Measurement of the Ventilatory Response to Hypoxia

COUNTERPOINT: Is the Apnea-Hypopnea Index the Best Way to Quantify the Severity of Sleep-Disordered Breathing? No Naresh M. Punjabi, MD, PhD, FCCP CHEST

Guidelines for Evaluating Chronic Cough in Pediatrics

Zaid J. Yaqoob, MD, Sadeer G. Al-Kindi, MD, Joe G. Zein, MD CHEST

Volume 142, Issue 1, Pages (July 2012)

Acute Pulmonary Exacerbations of Sarcoidosis

Millennial Health Care

Has the 6-Min Walk Distance Run Its Course?

Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation Nicholas J. Gross, MD,

Details and Difficulties Regarding the New Lung Cancer Staging System

Counterpoint: Adherence to Early Goal-Directed Therapy

Global Physiology and Pathophysiology of Cough

Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP

Evidence-Based Asthma Guidelines

Bronchospasm Secondary to Replacement Estrogen Therapy

Point: Should Medicare Allow Respiratory Therapists to Independently Practice and Bill for Educational Activities Related to COPD? Yes Thomas M. Fuhrman,

Sundeep Salvi, MD, DNB, PhD, FCCP, Peter J. Barnes, DM, FCCP CHEST

Volume 104, Issue 1, Pages 1-2 (July 1993)

New CHEST Associate Editors Named

Imaging for the Management of Community-Acquired Pneumonia

Point: Should We Abandon FEV1/FVC <0

Current Practice in Pulmonary Function Testing

Brahms' Lullaby Revisited

Guidelines for Evaluating Chronic Cough in Pediatrics

Bedside Calibration Of Pulmonary Artery Catheters

Invasive Pulmonary Aspergillosis

Pulmonary Manifestations in a Case of Multiple Myeloma

A Single Nasal Prong for Continuous Oxygen Therapy

Nasal Airflow in Sleep-Disordered Breathing

Ribavirin in Desquamative Interstitial Pneumonia

Counterpoint: Should Paralytic Agents Be Routinely Used in Severe ARDS

Volume 115, Issue 6, Pages (June 1999)

Thoracic Surgery Survey on Lung Cancer Management

Digitalis and Angina Pectoris

Volume 133, Issue 4, Pages (April 2008)

Rebuttal From Drs Mohr and Doerschug

Ipratropium Bromide Bronchodilator Solution

New Members of the Editorial Board

Rebuttal From Dr Kollef

John Reid, MD, Donald Cockcroft, MD CHEST

A 23-Year-Old Man With Dyspnea During Myasthenia Crisis

Presentation transcript:

Session 9: Management of COPD Leonard D. Hudson, M.D., F.C.C.P. CHEST Volume 85, Issue 6, Pages 76S-81S (June 1984) DOI: 10.1378/chest.85.6_Supplement.76S Copyright © 1984 The American College of Chest Physicians Terms and Conditions

Figure 2 Improvement in spirometry prebronchodilator. FEV1 = forced expiratory volume in 1 s; FVC=forced vital capacity. Patients receiving methylprednisolone had a greater improvement in airflow than did those receiving placebo. (from Albert et al, Ann Intern Med 1980; 92:753-58, by permission) CHEST 1984 85, 76S-81SDOI: (10.1378/chest.85.6_Supplement.76S) Copyright © 1984 The American College of Chest Physicians Terms and Conditions

Figure 4 Survival data from both the National Institutes of Health sponsored Nocturnal Oxygen Therapy trial and the British Medical Research Council study. The display shows that in the Nocturnal Oxygen Therapy Trial, continuous oxygen therapy (COT) had improved survival over nocturnal oxygen therapy (NOT). Nocturnal oxygen therapy was similar to oxygen used for approximately 15 hours per day in the MRC study and this had better survival than the MRC control group. (Figure supplied by Dr. David Flenley.) CHEST 1984 85, 76S-81SDOI: (10.1378/chest.85.6_Supplement.76S) Copyright © 1984 The American College of Chest Physicians Terms and Conditions